"HCV is transmitted through blood contact between an infected individual and someone who is not infected."
London, April 14 - In what could revolutionise treatment of patients infected with hepatitis C virus -, scientists have isolated a new compound from Chinese herbal medicines that can inhibit HCV activity by approximately 90 percent.

The new compound, SBEL1, was extracted from a herb found in certain regions of Taiwan and Southern China.

In Chinese medicine, it is used to treat sore throats and inflammations. The function of SBEL1 within the plant is unknown and its role and origins are currently being investigated.

Recent advances means that we can now virtually cure HCV without unpleasant side effects, said Markus Peck-Radosavljevic, associate professor of medicine at University of Vienna in Austria.

In the past, less than 20 percent of all HCV patients were treated because the available treatments were unsuitable due to poor efficacy and high toxicity, Peck-Radosavljevic said.

For the research, scientists pre-treated human liver cells in vitro with SBEL1 prior to HCV infection and found that SBEL1 pre-treated cells contained 23 percent less HCV protein than the control, suggesting that SBEL1 blocks virus entry.

SBEL1 has demonstrated significant inhibition of HCV at multiple stages of the viral lifecycle, which is an exciting discovery because it allows us to gain a deeper understanding of the virus and its interactions with other compounds, Peck-Radosavljevic noted.

There are an estimated 150 million to 200 million people living with chronic HCV and more than 350,000 people die annually from HCV-related diseases.

HCV is transmitted through blood contact between an infected individual and someone who is not infected.

This can occur through needlestick injuries or sharing of equipment used to inject drugs.


comments powered by Disqus
Read more on:
 SCIENTISTS (13481 views)
 BLOOD (11961 views)
 VIENNA (9479 views)
 LIVER (8191 views)
 VIRUS (6371 views)
 TREATMENT (6241 views)
 MMA (6051 views)
 AUSTRIA (5621 views)
 TAIWAN (5501 views)
 NSUI (4841 views)
 HEPATITIS (3658 views)
 ASSOCIATE PROFESSOR (2941 views)
 UGS (2871 views)
 HERBAL (2371 views)
 INFLAMMATION (2163 views)
 CHINESE MEDICINE (2041 views)
 HEPATITIS C VIRUS (1051 views)
 PROTEIN (731 views)
 IN VITRO (451 views)
 HEPATITIS C (411 views)
 HCV (341 views)
 HERBAL MEDICINE (261 views)
 

PERMALINK

http://www.nerve.in/news:2535002323033
You can quote the permanent link above for a direct link to the story. We do not archive or expire our news stories.


STORY OPTIONS
  Email this story to a friend
  XML feed for Europe


 
COPYRIGHTS INFORMATION
All rights reserved for news content. Reproduction, storage or redistribution of Nerve content and articles in any medium is strictly prohibited.
Contact Nerve Staff for any feedback, corrections and omissions in news stories.
 

All rights reserved for the news content. Reproduction, storage or redistribution of Nerve content and articles in any medium is strictly prohibited.